Skip to content

TIC Solutions TIC Noncash lease expense

Noncash lease expense at other companies

Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$994K+19.0%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$1.34M+19.4%
Astrana Health logo
Astrana HealthASTH
$2.01M+55.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$77K-53.0%
Disc Medicine logo
Disc MedicineIRON
$129K+15.2%
BlackLine logo
BlackLineBL
$1.55M+10.6%

Other financials

Income statement

See full
Revenue$488.0M+108%
Gross profit$161.3M+269%
Operating income-$29.1M-208%
Net income-$41.5M-61.1%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$426.6M+174%
Total debt$1.7B+110%
Total equity$2.1B+89.0%
Total assets$4.3B+98.7%

Cash flow

See full
Operating cash flow$9.9M-69.7%
CapEx$5.7M+27.3%
Free cash flow$4.2M-85.1%

Valuation

See full
Market cap$1.81B
Enterprise value$3.08B
P/S

Profitability

See full
Gross margin31.8%+8.0pp
Operating margin-2.1%-0.9pp
Net margin-5.8%-2.2pp
FCF margin4.5%

Returns & leverage

See full
Return on equity-6.3%
Debt / equity0.8×+0.1×
Current ratio3.1×-0.4×

Where this comes from

Reported directly by TIC Solutions in its filing.

Tagged under the XBRL concept tic:NoncashLeaseExpense.

The official record: TIC Solutions ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TIC Solutions 's noncash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TIC Solutions 's noncash lease expense?
TIC Solutions (TIC) reported noncash lease expense of $6.04M in Q1 2026.
How has TIC Solutions 's noncash lease expense changed year-over-year?
TIC Solutions 's noncash lease expense increased by 142.3% year-over-year, from $2.49M to $6.04M.
What does noncash lease expense mean?
This represents the portion of lease expenses recognized in the income statement that does not involve an immediate cash outflow. It reflects the systematic allocation of the right-of-use asset cost over the lease term, providing insight into the company's non-cash operating burden. Monitoring this helps analysts distinguish between actual cash-based lease payments and accounting-driven expense recognition.